Larvol Delta - Achievement-of-Low-Disease-Activity-and-Remission-in-Dermatomyositis-Patients-Treated-with-Brepocitinib-Analyses-from-the-Phase-3-VALOR-Trial

Lisraya (brepocitinib) - Priovant Therap

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1896657&mode=presInfo

iazsmin Ventura, MD, MSc

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next